(Q37710955)

22 August 2017

A new laboratory-based algorithm to predict development of hepatocellular carcinoma in patients with hepatitis C and cirrhosis (English)

1 reference

22 August 2017

0 references

0 references

1 reference

hepatocellular carcinoma

1 reference

1 reference

1

Hashem B El-Serag

1 reference

22 August 2017

4

Jennifer Kramer

1 reference

22 August 2017

5

Peter Richardson

1 reference

22 August 2017

3

Jessica A Davila

1 reference

22 August 2017

2

Fasiha Kanwal

1 reference

PMC publication ID

3992177

22 August 2017

language of work or name

English

0 references

publication date

23 January 2014

1 reference

22 August 2017

1 reference

22 August 2017

146

1 reference

22 August 2017

5

1 reference

22 August 2017

1249-55.e1

1 reference

A Bayesian Approach to Pathway Analysis by Integrating Gene-Gene Functional Directions and Microarray Data

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992177

Improving screening for hepatocellular carcinoma by incorporating data on levels of α-fetoprotein, over time

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992177

Determinants of serum alpha-fetoprotein levels in hepatitis C-infected patients

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992177

Entropy-based information gain approaches to detect and to characterize gene-gene and gene-environment interactions/correlations of complex diseases

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992177

Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992177

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992177

Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992177

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992177

Phases of biomarker development for early detection of cancer

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992177

Risk prediction models: II. External validation, model updating, and impact assessment

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992177

External validation is necessary in prediction research: a clinical example

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992177

α-Fetoprotein in hepatocellular carcinoma surveillance: mend it but do not end it.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992177

Utilization of screening for hepatocellular carcinoma in the United States.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992177

Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992177

Finding useful questions: on Bayesian diagnosticity, probability, impact, and information gain.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992177

Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992177

Screening for hepatocellular carcinoma: The rationale for the American Association for the Study of Liver Diseases recommendations

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992177

Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study

3 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24462733

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1053/J.GASTRO.2014.01.045

1 reference

22 August 2017

1 reference

PMC publication ID

3992177

22 August 2017

PubMed publication ID

24462733

1 reference

PMC publication ID

3992177